Ataxia

  • PIC logo
    PIC Endorsed
  • See also

    Acute poisoning
    Head injury
    Metabolic disorders
    Stroke

    Key points

    1. Assessment focuses on a thorough evaluation for serious and treatable causes including CNS infection or inflammation, trauma, stroke, toxin ingestion and mass lesions
    2. Post-infectious acute cerebellar ataxia is the most common cause, it is self-limiting and is a diagnosis of exclusion
    3. Some conditions present with an unsteady gait due to weakness or pain. A frightened or very unwell child may also appear ataxic

    Background

    Ataxia is defined as unsteadiness, imbalance or clumsiness due to uncoordinated muscle movements, and presents as abnormal gait, speech or motor skills

    Classification & causes

    Acute (<72 hours duration, previously well child)

    Chronic

    Recurrent

    Post-infectious*
    Toxins*
    Tumours*
    Trauma*
    Metabolic
    Infections
    Vascular, may require urgent lysis see Stroke
    Immune (eg ADEM, Guillain Barre Syndrome)
    Functional neurological disorder 

    Brain tumours
    Hydrocephalus
    Metabolic
    Nutritional
    Congenital malformations
    Hereditary ataxia
    Trauma
    Functional neurological disorder 

    Episodic ataxia   
    Basilar artery migraine
    Seizure disorder
    Metabolic 
    Demyelinating pathology
    Functional neurological disorder 

    *Most common causes

    Common causes of acute ataxia

     

    Cause

    Timing

    Clinical features

    Post- infectious acute cerebellar ataxia

    Viral (eg varicella, EBV, HHV6,
    Enteroviruses)
    Mycoplasma

    Most commonly occurs 5-10 days after a prodromal illness

    Commonly affects children 2-7 years of age
    Features of cerebellar ataxia which are maximal at onset and usually improve within 48-72 hours.
    Full recovery usually occurs within 10-21 days (>90% resolve by 2 months)

    Toxins

    Antihistamines
    Antiepileptics
    Ethanol, ethylene glycol or isopropyl
    Sedative-hypnotics

    Variable and dose related

    History of potential access to medications, environmental exposure or a recent change to medications 
    Altered GCS or toxidrome

    Tumours

    Oedema
    Obstructive hydrocephalus
    Haemorrhage

    Acute or acute on chronic

    Usually present with normal conscious level
    Features of raised ICP
    Constitutional symptoms
    Focal neurological deficits

    Trauma

    Haemorrhage
    Contusion
    Diffuse axonal injury
    Concussion

    Both acute and chronic

    History or clinical findings of head injury
    Risk factors for NAI

     

    ADEM

    Autoimmune condition leading to demyelination of the CNS

    Typically occurs 1-4 weeks after a febrile illness

    Lethargy or irritability associated with multiple neurological deficits including pyramidal signs, optic neuritis, hemiplegia, ataxia

    Assessment

    History

    • Time course (acute <72 hours)
    • Antecedents include
      • recent viral illness
      • rash
      • head trauma
      • earache
    • Symptoms of ataxia
      • clumsiness, falls, broad based or staggering gait
      • difficulty sitting upright
      • slurred speech
      • swallowing difficulties
    • Other neurological symptoms, including:
      • behavioural change
      • photophobia
      • vertigo
    • Family history, including:
      • metabolic disease
      • hereditary ataxia
      • migraine
      • seizure disorder
    • Drugs/toxins or environmental exposures

    Examination

    • Conscious state, orientation
    • Thorough neurological examination is essential
    • Exclude signs of meningoencephalitis (fever, meningism)
    • Features suggestive ofcerebellar ataxia
      • Cerebellar signs (dysdiadochokinesis, dysmetria, dysarthria, tremor, nystagmus)
      • Gait abnormalities (staggering and/or wide-based)
    • Features suggestive of sensory ataxia
      • Positive Romberg test
      • Loss of light touch, vibration and proprioception
      • Hyporeflexia
    • Features suggestive of vestibular ataxia
      • Nystagmus without other cerebellar signs

    Red flag features

    • Signs of raised intracranial pressure
    • Altered conscious state
    • Focal neurology
    • Meningism
    • Loss of proprioception, vibration sense or tactile discrimination
    • Weakness
    • Abnormal deep tendon reflexes

    Management

    Ataxia diagram


    Investigations

    If features are consistent with post-infectious acute cerebellar ataxia, then no investigations may be necessary

     
    If ataxia does not resolve within 72 hours, worsens any time after onset or another cause is suspected, consider:

    Bloods

    Imaging

     Other

    Blood glucose
    Venous Blood gas
    Electrolytes
    Liver function tests
    Anticonvulsant level, ethanol

    Neuroimaging (CT or MRI depending on likely cause and availability)

    Toxicology
    Metabolic screening
    Viral studies
    Vitamin B12 levels
    Lumbar puncture (after neuroimaging)
    EEG

    Treatment

    Treatment will depend on cause, children with a presentation consistent with post-infectious acute cerebellar ataxia generally require no treatment

    Consider consultation with local paediatric team when

    • A child with an acute ataxia of unclear aetiology
    • A child with chronic or recurrent ataxia

    Consider transfer when

    • Other focal neurological signs
    • Raised ICP present
    • History not typical of post-infectious acute cerebellar ataxia or aetiology is unclear
    • Child requiring care beyond the comfort level of the hospital

    For emergency advice and paediatric or neonatal ICU transfers, see Retrieval Services

    Consider discharge when

    The cause of ataxia is clear, the child is clinically well and there is a follow up arranged
     

    Last updated August 2024

  • Reference List

    1. Gana S et al. Movement Disorders in Genetic Pediatric Ataxias. Movement Disorders Clinical Practice. 2020. 7 (4), p383-393. Retrieved from https://doi.org/10.1002/mdc3.12937
    2. Lancella L et al. Acute cerebellitis in children: an eleven year retrospective multicentric study in Italy. Ital J Pediatr. 2017. 43 (54). Retrieved from https://doi.org/10.1186/s13052-017-0370-z
    3. Overby P et al.  Acute Ataxia in Children. Pediatrics in Review. 2019. 40 (7), p332-343. Retrieved from https://doi.org/10.1542/pir.2017-0223
    4. Pavone P et al. Ataxia in children: early recognition and clinical evaluation. Italian Journal of Pediatrics. 2017. 43 (6). Retrieved from https://doi.org/10.1186/s13052-016-0325-9
    5. Salmon MS et al. Recurrent Ataxia in Children and Adolescents. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2017. 44, p375-383
    6. Whelan HT et al. Evaluation of the child with acute ataxia: a systematic review. Pediatric Neurology. 2013. 49 (1), p15-24